163 related articles for article (PubMed ID: 16583356)
1. High-level expression, activation, and subcellular localization of p38-MAP kinase in thyroid neoplasms.
Pomérance M; Quillard J; Chantoux F; Young J; Blondeau JP
J Pathol; 2006 Jul; 209(3):298-306. PubMed ID: 16583356
[TBL] [Abstract][Full Text] [Related]
2. p38 mitogen-activated protein kinase contributes to cell cycle regulation by cAMP in FRTL-5 thyroid cells.
Corrèze C; Blondeau JP; Pomérance M
Eur J Endocrinol; 2005 Jul; 153(1):123-33. PubMed ID: 15994754
[TBL] [Abstract][Full Text] [Related]
3. Inverse correlation between heparan sulfate composition and heparanase-1 gene expression in thyroid papillary carcinomas: a potential role in tumor metastasis.
Xu X; Quiros RM; Maxhimer JB; Jiang P; Marcinek R; Ain KB; Platt JL; Shen J; Gattuso P; Prinz RA
Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5968-79. PubMed ID: 14676122
[TBL] [Abstract][Full Text] [Related]
4. p38 mitogen-activated protein kinase plays a key role in regulating MAPKAPK2 expression.
Sudo T; Kawai K; Matsuzaki H; Osada H
Biochem Biophys Res Commun; 2005 Nov; 337(2):415-21. PubMed ID: 16198317
[TBL] [Abstract][Full Text] [Related]
5. FAM172A protein promotes the proliferation of human papillary thyroid carcinoma cells via the p38 mitogen-activated protein kinase pathway.
Li MF; Zhang R; Guo MG; Li LX; Lu HK; Lu JX; Jia WP
Mol Med Rep; 2016 Jan; 13(1):353-8. PubMed ID: 26573560
[TBL] [Abstract][Full Text] [Related]
6. Expression of Aurora kinases in human thyroid carcinoma cell lines and tissues.
Ulisse S; Delcros JG; Baldini E; Toller M; Curcio F; Giacomelli L; Prigent C; Ambesi-Impiombato FS; D'Armiento M; Arlot-Bonnemains Y
Int J Cancer; 2006 Jul; 119(2):275-82. PubMed ID: 16477625
[TBL] [Abstract][Full Text] [Related]
7. Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.
Weyemi U; Caillou B; Talbot M; Ameziane-El-Hassani R; Lacroix L; Lagent-Chevallier O; Al Ghuzlan A; Roos D; Bidart JM; Virion A; Schlumberger M; Dupuy C
Endocr Relat Cancer; 2010 Mar; 17(1):27-37. PubMed ID: 19779036
[TBL] [Abstract][Full Text] [Related]
8. DNFB activates MAPKs and upregulates CD40 in skin-derived dendritic cells.
Matos TJ; Duarte CB; Gonçalo M; Lopes MC
J Dermatol Sci; 2005 Aug; 39(2):113-23. PubMed ID: 15896946
[TBL] [Abstract][Full Text] [Related]
9. The natural protein kinase C alpha mutant is present in human thyroid neoplasms.
Prévostel C; Alvaro V; de Boisvilliers F; Martin A; Jaffiol C; Joubert D
Oncogene; 1995 Aug; 11(4):669-74. PubMed ID: 7651730
[TBL] [Abstract][Full Text] [Related]
10. Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia.
Tanno M; Bassi R; Gorog DA; Saurin AT; Jiang J; Heads RJ; Martin JL; Davis RJ; Flavell RA; Marber MS
Circ Res; 2003 Aug; 93(3):254-61. PubMed ID: 12829618
[TBL] [Abstract][Full Text] [Related]
11. Expression of inducible nitric oxide synthase in thyroid neoplasms: immunohistochemical and molecular analysis.
Choe W; Kim S; Hwang TS; Lee SS
Pathol Int; 2003 Jul; 53(7):434-9. PubMed ID: 12828608
[TBL] [Abstract][Full Text] [Related]
12. BRAF mediates RET/PTC-induced mitogen-activated protein kinase activation in thyroid cells: functional support for requirement of the RET/PTC-RAS-BRAF pathway in papillary thyroid carcinogenesis.
Mitsutake N; Miyagishi M; Mitsutake S; Akeno N; Mesa C; Knauf JA; Zhang L; Taira K; Fagin JA
Endocrinology; 2006 Feb; 147(2):1014-9. PubMed ID: 16254036
[TBL] [Abstract][Full Text] [Related]
13. p44/p42-MAP kinase expression in papillary thyroid carcinomas.
Specht MC; Barden CB; Fahey TJ
Surgery; 2001 Dec; 130(6):936-40. PubMed ID: 11742320
[TBL] [Abstract][Full Text] [Related]
14. Protein kinase C activity in human thyroid carcinoma and adenoma.
Hatada T; Sakanoue Y; Kusunoki M; Kobayashi A; Utsunomiya J
Cancer; 1992 Dec; 70(12):2918-22. PubMed ID: 1451074
[TBL] [Abstract][Full Text] [Related]
15. The role of differential activation of p38-mitogen-activated protein kinase in preconditioned ventricular myocytes.
Saurin AT; Martin JL; Heads RJ; Foley C; Mockridge JW; Wright MJ; Wang Y; Marber MS
FASEB J; 2000 Nov; 14(14):2237-46. PubMed ID: 11053245
[TBL] [Abstract][Full Text] [Related]
16. MAP kinase kinase 6-p38 MAP kinase signaling cascade regulates cyclooxygenase-2 expression in cardiac myocytes in vitro and in vivo.
Degousee N; Martindale J; Stefanski E; Cieslak M; Lindsay TF; Fish JE; Marsden PA; Thuerauf DJ; Glembotski CC; Rubin BB
Circ Res; 2003 Apr; 92(7):757-64. PubMed ID: 12649265
[TBL] [Abstract][Full Text] [Related]
17. Telomerase activity in human thyroid carcinomas originating from the follicular cells.
Brousset P; Chaouche N; Leprat F; Branet-Brousset F; Trouette H; Zenou RC; Merlio JP; Delsol G
J Clin Endocrinol Metab; 1997 Dec; 82(12):4214-6. PubMed ID: 9398742
[TBL] [Abstract][Full Text] [Related]
18. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase.
Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH
J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900
[TBL] [Abstract][Full Text] [Related]
19. Decreased p38 MAPK activity in end-stage failing human myocardium: p38 MAPK alpha is the predominant isoform expressed in human heart.
Lemke LE; Bloem LJ; Fouts R; Esterman M; Sandusky G; Vlahos CJ
J Mol Cell Cardiol; 2001 Aug; 33(8):1527-40. PubMed ID: 11448140
[TBL] [Abstract][Full Text] [Related]
20. p38alpha and p38delta mitogen-activated protein kinase isoforms regulate invasion and growth of head and neck squamous carcinoma cells.
Junttila MR; Ala-Aho R; Jokilehto T; Peltonen J; Kallajoki M; Grenman R; Jaakkola P; Westermarck J; Kähäri VM
Oncogene; 2007 Aug; 26(36):5267-79. PubMed ID: 17334397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
